[
    [
        {
            "time": "2018-04-25",
            "original_text": "Equifax's (EFX) Q1 Earnings Beat Estimates, Revenues Lag",
            "features": {
                "keywords": [
                    "Equifax",
                    "Q1 Earnings",
                    "Beat Estimates",
                    "Revenues Lag"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "finance"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Equifax's (EFX) Q1 Earnings Beat Estimates, Revenues Lag",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-04-26",
            "original_text": "Charles River Associates (CRAI) Lags Q1 Earnings Estimates",
            "features": {
                "keywords": [
                    "Charles River Associates",
                    "CRAI",
                    "Lags",
                    "Q1 Earnings",
                    "Estimates"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "consulting"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Charles River Associates (CRAI) Lags Q1 Earnings Estimates",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-05-03",
            "original_text": "Here’s What Hedge Funds Think About Adaptimmune Therapeutics plc (ADP)",
            "features": {
                "keywords": [
                    "Hedge Funds",
                    "Adaptimmune Therapeutics",
                    "plc",
                    "ADP"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Here’s What Hedge Funds Think About Adaptimmune Therapeutics plc (ADP)",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 7,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]